Abstract:figure legend Growth differentiation factor 15 (GDF15) has sex‐specific effects on body weight and food intake. In male mice, GDF15 prevents body weight gain through a reduction in total food intake. In female mice, daily GDF15 treatment did not prevent body weight gain. Despite inducing acute periods of reduced food intake, GDF15 did not reduce total food intake in female mice. GDF15 reduced voluntary wheel running in both sexes, which may limit beneficial adaptations to increased physical activity. Growth differentiation factor 15 (GDF15) is a stress‐induced cytokine that suppresses food intake and causes weight loss. GDF15 also reduces voluntary physical activity and, thus, it is not clear whether combining GDF15 with exercise will be beneficial or if reductions in food intake would be offset by decreases in physical activity. We investigated how GDF15 treatment combined with voluntary wheel running (VWR) would impact weight gain, food intake, adiposity and indices of metabolic health in mice. High‐fat fed male and female mice underwent daily GDF15 treatments and were given access to voluntary running wheels, or not, for 11 days. In both sexes, VWR prevented weight gain. In males, GDF15 reduced food intake, as well as attenuated weight gain and the accumulation of adipose tissue, with no additional effect of VWR. In female mice, GDF15 did not impact body weight gain or body composition. GDF15 acutely reduced food intake in female mice but this was followed by a period of rebound hyperphagia and consequently GDF15 did not reduce total food intake in female mice. GDF15 treatment reduced wheel running distance in both sexes. There were main effects of VWR to improve glucose tolerance in female but not male mice. These findings show that GDF15 has sex‐specific effects on food intake and consequently weight gain and adiposity. There is no added benefit of combining GDF15 and voluntary physical activity for weight loss. Adaptive responses to acute caloric restriction induced by GDF15 might limit its effectiveness as a weight loss tool in females. Key points GDF15 is a stress‐induced signalling factor that reduces food intake and voluntary physical activity. It is not known whether combining GDF15 treatment with voluntary wheel running would impart beneficial combined effects in attenuating weight gain and the accumulation of adipose tissue. In the present study, we demonstrate that GDF15 reduces food intake and prevents weight gain in male but not female mice consuming a high‐fat diet and also that combining GDF15 with voluntary wheel running (VWR) does not lead to a greater dampening of weight gain. In female mice, GDF15 acutely reduced food intake, but this was followed by a period of rebound hyperphagia resulting in no differences in total food intake. In both sexes, VWR was equivalent, or superior to GDF15 in preventing weight gain.

GDF15 is dispensable for the insulin-sensitizing effects of chronic exercise

GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans

Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15

GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion

GDF15 Associates with, but is not Responsible for, Exercise-Induced Increases in Corticosterone and Indices of Lipid Utilization in Mice

Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise

GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism

GDF15 is required for maintaining subcutaneous adipose tissue lipid metabolic signature

GDF15 promotes weight loss by enhancing energy expenditure in muscle

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

GDF15 deficiency promotes high fat diet-induced obesity in mice

Hepatocyte-derived GDF15 suppresses feeding and improves insulin sensitivity in obese mice

Acute Exercise Increases GDF15 and Unfolded Protein Response/Integrated Stress Response in Muscle in Type 2 Diabetes

Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial

Effects of acute exercise and exercise training on plasma GDF15 concentrations and associations with appetite and cardiometabolic health in individuals with overweight or obesity - A secondary analysis of a randomized controlled trial

Activation of the hypothalamic–pituitary–adrenal axis by exogenous and endogenous GDF15

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL

Daily GDF15 treatment has sex‐specific effects on body weight and food intake and does not enhance the effects of voluntary physical activity in mice

Comprehensive Role of GDF15 in Inhibiting Adipogenesis and Hyperlipidemia, Enhancing Cardiovascular Health and Alleviating Inflammation in Metabolic Disorders

GDF15 is required for cold-induced thermogenesis and contributes to improved systemic metabolic health following loss of OPA1 in brown adipocytes

GDF15 antagonism limits severe heart failure and prevents cardiac cachexia